Recent Advances on A3 Adenosine Receptor Antagonists by QSAR Tools

E-ISSN： 1873-4294|12|8|878-894

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.8, 2012-04, pp. : 878-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances on QSAR-Based Profiling of Agonist and Antagonist A3 Adenosine Receptor Ligands

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-05 ,pp. : 1048-1068

Bentham Science Publishers

Access to resources Recommend Favorite

A3 Adenosine Receptor Antagonists

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 4, 2001-11 ,pp. : 417-427

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in neurokinin-3 receptor antagonists

By Giardina G.A. Grugni M. Raveglia L.F.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 939-960

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in the field of A 2A and A 3 adenosine receptor antagonists

By Baraldi P.G. Tabrizi M.A. Bovero A. Avitabile B. Preti D. Fruttarolo F. Romagnoli R. Varani K. Borea P.A.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 367-382

Elsevier

Access to resources Recommend Favorite

Response Surface Analysis as Alternative 3D-QSAR Tool: Human A3 Adenosine Receptor Antagonists as a Key Study

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 122-127

Bentham Science Publishers

Access to resources Recommend Favorite